NASDAQ$DH
Definitive Healthcare Corp · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Definitive Healthcare's Q4 2022 financial results were reported, showcasing substantial revenue growth and improved net income.
Definitive Healthcare reported a 31% increase in revenue for Q4 2022, reaching $60.6 million, along with a GAAP net income of $6.7 million compared to a net loss of $(14.8) million in Q4 2021. The company's adjusted EBITDA also increased to $17.0 million, representing 28% of revenue.
- Revenue increased by 31% year-over-year to $60.6 million.
- GAAP Net Income was $6.7 million, compared to a $(14.8) million loss in Q4 2021.
- Adjusted Net Income increased to $10.5 million, compared to $6.6 million in Q4 2021.
- Adjusted EBITDA was $17.0 million, representing 28% of revenue, compared to $13.1 million in Q4 2021.
Headline financials
Revenue & EPS history
Definitive Healthcare · Revenue · Quarterly
$60.6M
Forward guidance
Definitive Healthcare provided financial guidance for Q1 2023 and the full year 2023, including revenue, adjusted operating income, adjusted EBITDA, and adjusted net income estimates.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2022
-3.2%
Avg return
Earnings day
-5.7%
Avg return
5 days after
-5.8%
Avg return
30 days after
39%
7 / 18 earnings
Positive
+31.7%
Q1 2025
Best reaction
-34.3%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.2% | -2.0% | -5.2% | |
| Q4 2025 | -8.6% | -12.9% | -25.0% | |
| Q3 2025 | +11.9% | +2.6% | -6.4% | |
| Q1 2025 | +31.7% | +21.4% | +33.1% | |
| Q4 2024 | -34.3% | -43.7% | -40.2% | |
| Q3 2024 | -1.4% | +6.3% | +8.4% | |
| Q2 2024 | -1.4% | +5.1% | +21.6% | |
| Q1 2024 | -27.1% | -27.5% | -22.9% | |
| Q4 2023 | +2.3% | -4.2% | -13.3% | |
| Q3 2023 | +27.5% | +29.5% | +49.5% | |
| Q2 2023 | -4.0% | -6.2% | -21.2% | |
| Q1 2023 | +0.9% | -3.7% | +7.9% | |
| Q4 2022 | +3.5% | -1.6% | -11.5% | |
| Q3 2022 | -25.0% | -29.7% | -14.5% | |
| Q2 2022 | -16.3% | -18.6% | -35.7% | |
| Q1 2022 | -17.5% | -31.3% | -19.4% | |
| Q4 2021 | +7.6% | +13.6% | +14.0% | |
| Q3 2021 | -5.8% | +0.2% | -23.3% | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro